Font: Financial Modeling Prep • Apr 21, 2026
Danaher Corporation (NYSE:DHR) reported first-quarter results that exceeded earnings estimates but fell short on revenue.
The company recorded adjusted earnings per share of $2.06, surpassing the analyst consensus of $1.94 by $0.12. Revenue totaled $5.95 billion, below the expected $5.99 billion, though it increased 3.5% compared to the prior-year quarter.
The revenue shortfall was attributed to a weaker-than-usual respiratory season impacting its Cepheid business, which offset strong performance in Bioprocessing and better-than-anticipated results in Life Sciences.
For the second quarter, Danaher projected core revenue growth in the low-single-digit percentage range. The company maintained its full-year core revenue growth outlook of 3% to 6% and raised its adjusted EPS guidance to a range of $8.35 to $8.55, up from its prior forecast of $8.35 to $8.50. The midpoint of $8.45 was above the analyst consensus estimate of $8.40.
|
FFAI§>
Faraday Future Intelligent Electric Inc.
|
$0.53
85.52%
|
|
BYND§>
Beyond Meat, Inc.
|
$1.05
-9.91%
|
|
CTNT§>
Cheetah Net Supply Chain Service Inc.
|
$0.04
-18.80%
|
|
FCHL§>
Fitness Champs Holdings Limited Common Stock
|
$0.28
26.00%
|
|
TZA§>
Direxion Daily Small Cap Bear 3X ETF
|
$5.14
2.90%
|
|
LOBO§>
Lobo EV Technologies Ltd.
|
$0.68
19.59%
|
|
ASBP§>
Aspire Biopharma Holdings, Inc.
|
$0.20
-24.86%
|
|
BURU§>
Nuburu, Inc.
|
$0.26
30.10%
|
|
RPGL§>
Republic Power Group Limited Class A Ordinary Shares
|
$0.72
59.21%
|
|
BITO§>
ProShares - Bitcoin ETF
|
$10.29
-1.63%
|